Viral subunit vaccines often contain immunodominant non-neutralizing epitopes that divert
host immune responses. These epitopes should be eliminated in vaccine design, but there …

Abstract The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) as a
cause of severe respiratory disease highlights the need for effective approaches to CoV …

Middle East respiratory syndrome (MERS) is a newly emerging infectious disease caused by
a novel coronavirus, MERS-coronavirus (MERS-CoV), a new member in the lineage C of β …

The recently identified Middle East respiratory syndrome coronavirus (MERS-CoV) causes
severe and fatal acute respiratory illness in humans. However, no prophylactic and …

Abstract The Middle East respiratory syndrome coronavirus (MERS-CoV), is an emerging
pathogen that continues to cause outbreaks in the Arabian peninsula and in travelers from …

The persistent public health threat of infection with Middle East respiratory syndrome
coronavirus (MERS-CoV) highlights the need for an effective and safe MERS-CoV vaccine …

In September 2012, a novel coronavirus was isolated from a patient who died in Saudi
Arabia after presenting with acute respiratory distress and acute kidney injury. Analysis …

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging virus that was
first reported in humans in June 2012 [1]. To date, MERS-CoV continues to infect humans …

Middle East respiratory syndrome (MERS) coronavirus (Co-V) contains a single spike (S)
protein, which binds to a receptor molecule, dipeptidyl peptidase 4 (DPP4; also known as …

Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV)
cases have been reported in more than 27 countries, and more than 2,000 cases have been …